NCT05111314View on ClinicalTrials.gov

Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 11, 2022

Primary Completion Date

August 14, 2023

Study Completion Date

August 14, 2023

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

Gallium Ga 68 Gozetotide

Given IA

PROCEDURE

Hepatic Artery Embolization

Undergo hepatic artery embolization

PROCEDURE

Positron Emission Tomography and Computed Tomography Scan

Undergo PET/CT scan

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05111314 - Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter